1. Home
  2. HQI vs CMPX Comparison

HQI vs CMPX Comparison

Compare HQI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HireQuest Inc. (DE)

HQI

HireQuest Inc. (DE)

HOLD

Current Price

$10.39

Market Cap

151.0M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.20

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HQI
CMPX
Founded
2002
2014
Country
United States
United States
Employees
65000
39
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.0M
927.5M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
HQI
CMPX
Price
$10.39
$5.20
Analyst Decision
Buy
Strong Buy
Analyst Count
1
9
Target Price
$13.00
$14.43
AVG Volume (30 Days)
10.8K
1.7M
Earning Date
05-07-2026
03-05-2026
Dividend Yield
2.34%
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$34,598,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$677.91
P/E Ratio
$31.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.38
$1.33
52 Week High
$13.76
$6.88

Technical Indicators

Market Signals
Indicator
HQI
CMPX
Relative Strength Index (RSI) 41.37 37.26
Support Level $9.29 $4.86
Resistance Level $11.72 $5.86
Average True Range (ATR) 0.65 0.29
MACD -0.12 -0.02
Stochastic Oscillator 11.74 15.53

Price Performance

Historical Comparison
HQI
CMPX

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: